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Background: At the time of diagnosis, Multiple Myeloma is commonly associated with renal impairment. Renal
tubular acidosis without overt renal insufficiency is an uncommon disease presentation of myeloma. Among tubular
acidosis types, isolated renal tubular acidosis is a very unusual presentation of multiple myeloma.
Case presentation: We present a 55 years old female who presented with lower limb weakness due to persistent
hypokalaemia caused by distal renal tubular acidosis. On further investigation of her anaemia with high erythrocyte
sedimentation rate, we diagnosed IgG myeloma.
Conclusion: Isolated distal renal tubular acidosis is a rare presentation of multiple myeloma. In the absence of
hypercalciuria and demonstrable light chain excretion in urine, we assumed that the distal renal tubular acidosis
could have been caused by monoclonal hypergammaglobulinaemic state of multiple myeloma.
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Renal Tubular Acidosis (RTA) is an infrequent finding asso-
ciated with Multiple Myeloma. Out of the types of renal
tubular acidosis, proximal RTA is well known to be associ-
ated with myeloma. It occurs due to the toxic effects of ex-
creted light chains on proximal renal tubular cells leading
to tubular dysfunction without overt renal insufficiency.
However, isolated distal tubular acidosis due to multiple
myeloma is very unusual and is only reported in few case
studies. The underlying pathogenesis of distal RTA second-
ary to multiple myeloma is not well described in literature.
We report a case of Multiple Myeloma leading to distal
tubular acidosis and bilateral nephrolithiasis without renal
impairment. In our case, there was no demonstrable light
chains detected in urine and there was no evidence of hy-
percalciuria to cause distal tubular involvement. There-
fore, in the absence of the above, our patient’s distal
tubulopathy could be a result of monoclonal hypergam-
maglobulinaemic state caused by multiple myeloma.* Correspondence: fonseka.lakmal@gmail.com
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We report a 55 year old female, who was diagnosed to have
chronic autoimmune hypothyroidism for past 5 years on
thyroxine, presented with insidious onset of constitutional
symptoms for 6 months duration. Her thyroid function
tests showed satisfactory control. Despite satisfactory con-
trol of thyroid function tests, she experienced a gradual but
profound loss of weight of thirty six (36 kg) kilograms with
loss of appetite for the same duration. She did not have any
past or contact history of tuberculosis or a past history of
malignant disease. She is not on any medication too. Over
the last few months, she was complaining of a worsening
generalized malaise, which affected her activities of daily liv-
ing. There was no muscle pain but complained that her
walking has become clumsy and it was difficult for her to
stand from the seated position. On examination, she was
cachectic with BMI of 19 kg/m2 and was found to be pale,
without icterus or palpable lymph nodes or organomegaly.
Neurological examination revealed reduced muscle power
in lower limbs with diminished reflexes without any sensory
deficit. Her fundoscopic examination was normal.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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chromic anaemia (8.9 g/dl) with rouleaux formation. She
had elevated ESR of 120 mm/1st hour and hypokalemia
(2.9 mmol/l). Liver function tests showed reversed albumin
to globulin ratio (Albumin – 29 g/l, Globulin – 50 g/l). On
further investigation, serum protein electrophoresis re-
vealed a monoclonal band in the gamma region. However,
her skeletal survey and urinary Bence Jones protein were
negative. In bone marrow aspiration, there were 15 % clonal
plasma cells and immunofixation revealed IgG myeloma.
After confirming the low potassium, we detected her
urinary excretion of potassium to be increased. Fur-
thermore, her arterial blood gas showed a marked
hyperchloraemic metabolic acidosis (pH 7.2, HCO3-
8.2 mmol/l) with normal anion gap (15 mmol/l). Her
urine pH was 7.5 and was high despite systemic acidosis
and the fractionated bicarbonate excretion was 3 %.
Her non-contrast CT of kidneys revealed bilateral non-
obstructing renal calculi (Fig. 1).
Her autoimmune markers namely ANA, Rheumatoid
factor, Complement levels were all normal. Her serum
ionized calcium level (1.1 mmol/l) and urinary excretion
of oxalate, phosphate, uric acid, calcium and citrate
levels were within normal range. Contrast CT scan of
chest and abdomen did not show evidence of sarcoidosis
or malignancy. The summary of the investigations is
depicted in Table 1.
Discussion
Renal involvement is a common finding in the diagnosis
of multiple myeloma, where nearly 30–40 % of patients
were found to have raised serum creatinine levels [1].
Myeloma can damage the kidney at multiple levels:
namely glomerular, tubular and interstitial. Two major
causes of renal insufficiency in patients with myelomaFig. 1 Non-contrast CT kidneys showing bilateral nephrolithiasisare light chain cast nephropathy and hypercalcemia.
Apart from that, renal insufficiency occurs due to light
chain (AL) amyloidosis, light chain deposition disease,
interstitial nephritis or could be drug-induced. However,
in rare occasions, monoclonal heavy chain deposition
and non-monoclonal protein related renal injury may
also occur [2].
Out of the various renal manifestations of myeloma,
renal tubular acidosis is an uncommon entity. Although
adult proximal tubular dysfunction is well described as
an association of myeloma; distal renal tubular acidosis
(dRTA) in the background of multiple myeloma is ex-
tremely rare. It is described only in few reports in litera-
ture. Proximal tubules are affected during the process
where the filtered light chains get reabsorbed and cata-
lyzed within the epithelial cells. These epithelial cells get
damaged with the activation of lysosomal enzymes and
from direct toxicity of light chains [3–5]. Distal tubules
are thought to be affected due to either hypercalciuria or
hypergammaglobulinaemia (usually polyclonal) [6, 7].
Among the case series of RTA with multiple myeloma,
DeFronzo et al [8] described in his series of 14 patients
with urinary acidification defects: two had distal tubular
involvement. Another Czech case series showed that
eight out of 21 patients developed distal renal tubular
defects [9]. Out of the three case reports which described
the association of dRTA and myeloma, first case report,
described a patient having early myeloma with IgG lambda
chains who developed distal RTA [5] and second, a patient
with Sjogrens’ syndrome subsequently developed mono-
clonal gammopathy of unknown significance (MGUS)
with dRTA [10]. Third report described a patient with IgA
kappa multiple myeloma with both proximal and distal
renal tubular involvement, probably due to the overflow of
light chains from proximal to the distal renal tubules and
deposition in the renal tubular epithelial cells [11]. But the
pathogenesis of dRTA was unclear in the above case re-
ports as they neither had hypercalciuria nor polyclonal
hypergammaglobulinaemia. But they had monoclonal
gammaglobulinaemia which may have caused dRTA in the
same mechanism in which polyclonal hypergammaglobu-
linaemia caused dRTA.
In our patient, the diagnosis of dRTA was made by
the presence of hypokalemia, hyperchloremic metabolic
acidosis with high urinary pH above 5.5. Distal tubular
involvement was confirmed by the presence of low
fractionated bicarbonate excretion and its association
with bilateral nephrolithiasis or nephrocalcinosis [11].
There was no proximal tubular involvement in our pa-
tient. It is mandatory to find a secondary cause for dRTA,
since concomitant treatment of RTA and the underlying
cause is important for a better prognosis [12]. Therefore,
we searched for a cause for the dRTA in our patient, in
the background of anaemia and high ESR. Autoimmune
Table 1 Summary of investigations
Urinalysis Arterial blood gas
Urine pH 7.5 pH 7.2
Protein Nil Bicarbonate 8.2 mmol/l
Glucose Nil pCO2 20 mmHg
Pus cells Few Base excess −17
Red cells 1–2 Anion gap 15 mmol/l
Casts Nil Fractionated bicarbonate excretion 3 %
Crystals Nil ANA Negative
Urinary anion gap Negative Complement levels (C3, C4) Normal
Urinary Sodium 32 mmol/l Rheumatoid factor Negative
Urinary Pottasium 45 mmol/l 24 h urinary excretion
Blood Biochemistry Oxalate 0.21 mmol/d (0.04–0.32)
Na 145 mmol/l Phosphate 25.6 mmol/d (12.9–42)
K 2.9 mmol/l Uric acid 476 mg/d (250–750)
Cl 115 mmol/l Calcium 5.1 mmol/d (2.5–7.5)
Glucose 105 mg/dl Citrate 720 mg/day (>600)
Total Protein 88 g/l Serum protein electrophoresis
Albumin 29 g/l Monoclanal band in gamma region
Globulin 59 g/l Paraproteinaemia 36.7 g/l
Creatinine 82 μmol/l Immunofixation IgG Kappa Myeloma
Ionized calcium 1.1 mmol/l Bone marrow aspiration
ALP 147 U/l 15 % bone marrow clonal plasma cells
Chest radiograph Normal
Contrast CT chest and abdomen Urine protein electrophoresis & Immunofixation
Bilateral nephrolithiasis Absent light chains in urine
Mantoux Negative
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men, transaminases and other screening for granuloma-
tous diseases were all negative. But, investigation of bone
marrow and serum protein electrophoresis led to the diag-
nosis of multiple myeloma. Immunofixation showed a
monoclonal peak (36.7 g/l) which could be the cause for
dRTA. Unfortunately, free light chain assay was not readily
available, hence urine immunofixation was performed and
it showed absent overt light chain excretion.
Pathogenesis of isolated dRTA due to myeloma is not
well described earlier. It is highly unlikely that light
chain deposition would cause to dRTA, as it’s known to
cause proximal RTA. Previous studies have demonstrated
an association between hypergammaglobulinemia and dis-
tal RTA [8, 13]. But the hypergammaglobulinamia, which
is associated with dRTA, is usually polyclonal [14]. Feringa
et al have described a case of Waldenstrom’s Macroglobu-
linaemia, in which IgM monoclonal hyperglobulinaemia
associated with dRTA [14]. Therefore, in the absence of
hypercalciuria in our patient, multiple myeloma inducedmonoclonal hypergammaglobulinaemia would have led to
dRTA. Unfortunately, renal biopsy has not been per-
formed on her, so that the exact pathogenesis was difficult
to ascertain.
Distal RTA can lead to bilateral nephrolithiasis due to
hypercalciuria, hyperphosphaturia, hypocitraturia, and low
urine pH. In the absence of hypercalciuria, hyperphospha-
turia, hypocitraturia, we assumed that urine pH has led to
the extensive stone formation in our patient [15].
Having arrived at the diagnosis of dRTA, we started
her on oral bicarbonate and oral potassium chloride. Her
lower limb weakness showed a marked improvement
with the normalization of potassium. Subsequently,
with correction of acidosis we could tail off potassium
supplementation. After obtaining Oncology opinion,
standard chemotherapy was initiated as the treatment
for myeloma and at 3 months of completion of chemother-
apy, her bicarbonate requirement and the inflammatory
markers were noted to be reduced and the monoclonal
band peak also reduced to 7.2 g/l. In our attempt of
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myeloma can improve the monoclonal gammopathy as
well as the RTA.
Conclusion
Our case illustrates that Multiple Myeloma can rarely
present as an isolated distal renal tubular acidosis with-
out overt renal insufficiency. Our investigations demon-
strated that the monoclonal hypergammaglobulinaemia
secondary to myeloma would have been the probable
cause for the dRTA in this patient. As the evidence of a
renal biopsy was not available, exact pathogenesis cannot
be explained, with certainty. With our experience, it was
evident that the treatment of myeloma could improve
both myeloma per se and the dRTA.
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